FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37889311000001108: Yasmin tablets (CST Pharma Ltd) 63 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
540581000001113 Yasmin tablets (CST Pharma Ltd) 63 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
540591000001110 Yasmin tablets (CST Pharma Ltd) 63 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Yasmin tablets (CST Pharma Ltd) 63 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Is a Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has AMP Yasmin tablets (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) 63 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start